| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.8 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |